{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:24:29Z","timestamp":1783416269448,"version":"3.54.6"},"reference-count":31,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2026.10663","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:39:45Z","timestamp":1778661585000},"source":"Crossref","is-referenced-by-count":0,"title":["Dual Targeting Strategy: Colchicine and Paclitaxel Combination Against Prostate Cancer Cells Colchicine-Paclitaxel Synergy in Prostate Cancer"],"prefix":"10.4274","author":[{"given":"Ceren","family":"SUMER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"SARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mertkaya","family":"ARAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Deniz","family":"USTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of in-cidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of in-cidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/cancers15205047","article-title":"Castration-resistant prostate cancer: from uncovered re-sistance mechanisms to current treatments","volume":"15","author":"TK","year":"2023","unstructured":"2. Le TK, Duong QH, Baylot V, et al. Castration-resistant prostate cancer: from uncovered re-sistance mechanisms to current treatments. Cancers (Basel). 2023;15:5047.","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Ruiz de Porras V, Font A, Aytes A. Chemotherapy in metastatic castration-resistant prostate cancer: current scenario and future perspectives. Cancer Lett. 2021 Dec 28;523:162-9.","DOI":"10.1016\/j.canlet.2021.08.033"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.3390\/cancers13225650","article-title":"Microtubule targeting agents in disease: classic drugs, novel roles","volume":"13","author":"Wordeman","year":"2021","unstructured":"4. Wordeman L, Vicente JJ. Microtubule targeting agents in disease: classic drugs, novel roles. Cancers (Basel). 2021;13:5650.","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","unstructured":"5. Alalawy AI. Key genes and molecular mechanisms related to paclitaxel resistance. Cancer Cell Int. 2024;24:244.","journal-title":"Cancer Cell Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","unstructured":"6. Leung YY, Yao Hui LL, Kraus VB. Colchicine--update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45:341-50.","journal-title":"Semin Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","unstructured":"7. Bayat Mokhtari R, Homayouni TS, Baluch N, et al. Combination therapy in combating cancer. Oncotarget. 2017;8:38022-38043.","journal-title":"Oncotarget"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13104-024-07050-w","article-title":"Comparison of baseline global gene expression profiles of prostate cancer cell lines LNCaP and DU145","volume":"17","author":"Ahmed","year":"2024","unstructured":"8. Ahmed K, Omarova Z, Sheikh A, Abuova G, Ghias K, Abidi SH. Comparison of baseline global gene expression profiles of prostate cancer cell lines LNCaP and DU145. BMC Res Notes. 2024;17:398.","journal-title":"BMC Res Notes"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6750-5-12","article-title":"A simple technique for quantifying apoptosis in 96-well plates","volume":"5","author":"Ribble","year":"2005","unstructured":"9. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5:12.","journal-title":"BMC Biotechnol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","unstructured":"10. Wu S, Li X, Gao F, de Groot JF, Koul D, Yung WKA. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. Neuro Oncol. 2021;23:920-31.","journal-title":"Neuro Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"MA","year":"2004","unstructured":"11. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253-65.","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/cancers7040897","article-title":"Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy","volume":"7","author":"AM","year":"2015","unstructured":"12. Barbuti AM, Chen ZS. Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy. Cancers (Basel). 2015;7:2360-71.","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Goodson HV, Jonasson EM. Microtubules and microtubule-associated proteins. Cold Spring Harb Perspect Biol. 2018;10:a022608.","DOI":"10.1101\/cshperspect.a022608"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/pros.2990260606","article-title":"Inhibition of prostate cancer growth by estra-mustine and colchicine","volume":"26","author":"Fakih","year":"1995","unstructured":"14. Fakih M, Yagoda A, Replogle T, Lehr JE, Pienta KJ. Inhibition of prostate cancer growth by estra-mustine and colchicine. Prostate. 1995;26:310-5.","journal-title":"Prostate"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.3390\/molecules27217183","article-title":"Paclitaxel induces the apoptosis of prostate cancer cells via ROS-mediated hif-1\u03b1 expression","volume":"27","author":"Zhang","year":"2022","unstructured":"15. Zhang Y, Tang Y, Tang X, Wang Y, Zhang Z, Yang H. Paclitaxel induces the apoptosis of prostate cancer cells via ROS-mediated hif-1\u03b1 expression. Molecules. 2022;27:7183.","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Cevik O, Acidereli H, Turut FA, Yildirim S, Acilan C. Cabazitaxel exhibits more favorable molecu-lar changes compared to other taxanes in androgen-independent prostate cancer cells. J Bio-chem Mol Toxicol. 2020;34:e22542.","DOI":"10.1002\/jbt.22542"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pros.23772","article-title":"Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis","volume":"79","author":"Xue","year":"2019","unstructured":"17. Xue YN, Yu BB, Liu YN, et al. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis. Prostate. 2019;79:647-56.","journal-title":"Prostate"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/jcb.23134","article-title":"Resistance to paclitaxel increases the sensitivity to other micro-environmental stresses in prostate cancer cells","volume":"112","author":"Li","year":"2011","unstructured":"18. Li Y, Zeng Y, Mooney SM, et al. Resistance to paclitaxel increases the sensitivity to other micro-environmental stresses in prostate cancer cells. J Cell Biochem. 2011;112:2125-37.","journal-title":"J Cell Biochem"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"105138","DOI":"10.1016\/j.tiv.2021.105138","article-title":"Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells","volume":"73","author":"Ergul","year":"2021","unstructured":"19. Ergul M, Bakar-Ates F. Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021;73:105138.","journal-title":"Toxicol In Vitro"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11033-024-09669-1","article-title":"Cytotoxic and mo-lecular differences of anticancer agents on 2D and 3D cell culture","volume":"51","author":"Alwahsh","year":"2024","unstructured":"20. Alwahsh M, Al-Doridee A, Jasim S, Awwad O, Hergenr\u00f6der R, Hamadneh L. Cytotoxic and mo-lecular differences of anticancer agents on 2D and 3D cell culture. Mol Biol Rep. 2024;51:721.","journal-title":"Mol Biol Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"DR","year":"2019","unstructured":"21. Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79:3011-27.","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"43359","DOI":"10.1074\/jbc.M112.423905","article-title":"The role of microtubules and their dynamics in cell migration","volume":"287","author":"Ganguly","year":"2012","unstructured":"22. Ganguly A, Yang H, Sharma R, Patel KD, Cabral F. The role of microtubules and their dynamics in cell migration. J Biol Chem. 2012;287:43359-69.","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1158\/1535-7163.MCT-13-0401","article-title":"Microtubule dynamics control tail retraction in migrating vascular endothelial cells","volume":"12","author":"Ganguly","year":"2013","unstructured":"23. Ganguly A, Yang H, Zhang H, Cabral F, Patel KD. Microtubule dynamics control tail retraction in migrating vascular endothelial cells. Mol Cancer Ther. 2013;12:2837-46.","journal-title":"Mol Cancer Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cm.21153","article-title":"Mechanisms of inhibition of endothelial cell migra-tion by taxanes","volume":"71","author":"Kamath","year":"2014","unstructured":"24. Kamath K, Smiyun G, Wilson L, Jordan MA. Mechanisms of inhibition of endothelial cell migra-tion by taxanes. Cytoskeleton (Hoboken). 2014;71:46-60.","journal-title":"Cytoskeleton (Hoboken)"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Cho JH, Joo YH, Shin EY, Park EJ, Kim MS. Anticancer effects of colchicine on hypopharyngeal cancer. Anticancer Res. 2017;37:6269-80.","DOI":"10.21873\/anticanres.12078"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1021\/acsbiomaterials.4c01226","article-title":"Tubulin-targeted therapy in melanoma increases the cell mi-gration potential by activation of the actomyosin cytoskeleton\u2500an in vitro study","volume":"10","author":"Luty","year":"2024","unstructured":"26. Luty M, Szydlak R, Pabijan J, et al. Tubulin-targeted therapy in melanoma increases the cell mi-gration potential by activation of the actomyosin cytoskeleton\u2500an in vitro study. ACS Biomater Sci Eng. 2024;10:7155-66.","journal-title":"ACS Biomater Sci Eng"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1172\/JCI34279","article-title":"Colchicine inhibits pres-sure-induced tumor cell implantation within surgical wounds and enhances tumor-free surviv-al in mice","volume":"118","author":"Craig","year":"2008","unstructured":"27. Craig DH, Owen CR, Conway WC, Walsh MF, Downey C, Basson MD. Colchicine inhibits pres-sure-induced tumor cell implantation within surgical wounds and enhances tumor-free surviv-al in mice. J Clin Invest. 2008;118:3170-80.","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.3892\/mmr.2015.4222","article-title":"Colchicine induces apoptosis in HT\u201129 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways","volume":"12","author":"Huang","year":"2015","unstructured":"28. Huang Z, Xu Y, Peng W. Colchicine induces apoptosis in HT\u201129 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol Med Rep. 2015;12:5939-44.","journal-title":"Mol Med Rep"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Zhang T, Chen W, Jiang X, et al. Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo. Biosci Rep. 2019;39:BSR20181802.","DOI":"10.1042\/BSR20181802"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.etp.2013.04.006","article-title":"Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition","volume":"65","author":"Morales-Cano","year":"2013","unstructured":"30. Morales-Cano D, Calvi\u00f1o E, Rubio V, et al. Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. Exp Toxicol Pathol. 2013;65:1101-8.","journal-title":"Exp Toxicol Pathol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3892\/or.2018.6622","article-title":"Zinc enhances chemosensitivity to paclitaxel in PC\u20113 prostate cancer cells","volume":"40","author":"Zhang","year":"2018","unstructured":"31. Zhang P, Li Y, Tang X, et al. Zinc enhances chemosensitivity to paclitaxel in PC\u20113 prostate cancer cells. Oncol Rep. 2018;40:2269-77.","journal-title":"Oncol Rep"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:46:56Z","timestamp":1783414016000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/dual-targeting-strategy-colchicine-and-paclitaxel-combination-against-prostate-cancer-cells-colchicine-paclitaxel-synergy-in-prostate-cancer\/doi\/MMJ.galenos.2026.10663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":31,"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2026.10663","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}